Latest News

More cases of cervical cancer are diagnosed in China each year than in any other nation. China accounts for about 20 per cent of all…

Zimbabwe may be known for its pristine wilderness, but it is also a country facing a major public health crisis in the form of high…

TruScreen’s breakthrough cervical cancer screening device is a viable and attractive alternative to traditional cervical screening methods.

TruScreen is pleased to provide a copy of its November 2019 Stakeholder newsletter.

Cervical cancer affects millions of women worldwide. It is a silent killer, it has a high prevalence outside of developed countries, and almost all cases…

Cervical cancer is one of the most preventable and treatable forms of cancer1, yet over a quarter of a million women die from the disease…

Cervical cancer is the fourth most common cancer in women, with more than half a million women diagnosed with the disease in 20181. In low-…

TruScreen’s cervical cancer screening device demonstrates improved sensitivity and specificity targeting pre-cancerous and cancerous cervical cells

Dr. Carolina Velasquez traveled to Vietnam to conduct clinical training and launch the TruScreen Pilot Study, being conducted out of Hanoi Gynaecology and Obstetrics Hospital.…

TruScreen is pleased to provide a copy of its July 2019 Stakeholders Newsletter, providing an update on TruScreen’s performance and highlights key initiatives underway.